¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"load factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
LLD factor
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
precipitation factor
ħÀüÀÎÀÚ
predisposing factor
¼±Çà¿äÀÎ
prognostic factor
¿¹ÈÄÀÎÀÚ
prolactin inhibitory factor
ÇÁ·Î¶ôƾºÐºñ¾ïÁ¦ÀÎÀÚ
prolactin releasing factor
ÇÁ·Î¶ôƾºÐºñÀÎÀÚ
properdin factor B
ÇÁ·ÎÆä¸£µòBÀÎÀÚ
properdin factor D
ÇÁ·ÎÆä¸£µòDÀÎÀÚ
properdin factor E
ÇÁ·ÎÆä¸£µòEÀÎÀÚ
protein synthesis factor
´Ü¹éÇÕ¼ºÀÎÀÚ
psychogenic factor
Á¤½Å¼ºÀÎÀÚ
psychological factor
½É¸®¿äÀÎ
psychosocial factor
½É¸®»çȸ¿äÀÎ
phantom scatter factor
ÆÒÅÒ»ê¶õ°è¼ö
quality factor
1. Áú¿ä¼Ò 2. Á¤¼ºÀÎÀÚ
racial factor
ÀÎÁ¾¿äÀÎ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
recruitment factor
µ¿¿øÀÎÀÚ
reducing factor
ȯ¿øÀÎÀÚ
reinforcing factor
°È¿äÀÎ
relaxing factor
ÀÌ¿ÏÀÎÀÚ
resistance factor
³»¼ºÀÎÀÚ, °ßµõÀÎÀÚ
resistancetransfer factor
³»¼ºÀü´ÞÀÎÀÚ
reticuloendothelial depressant factor
¼¼¸Á³»Çǰè¾ïÁ¦ÀÎÀÚ, ±×¹°³»Çǰè¾ïÁ¦ÀÎÀÚ
rheumatoid factor
·ù¸¶Æ¼½ºÀ¯»çÀÎÀÚ
risk factor
À§ÇèÀÎÀÚ
roentgen-to-rad conversion factor
·ÛÆ®°Õ¶óµåº¯È¯°è¼ö
safety factor
¾ÈÀü°è¼ö
scatter factor
»ê¶õ°è¼ö
sebotropic factor
Áö·çÃËÁøÀÎÀÚ
skin vascular permeability factor
ÇǺÎÇ÷°üÅõ°úÀÎÀÚ
somatotropin release inhibiting factor
¼ºÀåÈ£¸£¸óÀ¯¸®¾ïÁ¦ÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
hypothalamic releasing factor
½Ã»óÇϺÎÀ¯¸®ÀÎÀÚ(ë¤×ãì×í).
hypothalamic releasing factor
½Ã»óÇϺιæÃâÀÎÀÚ.
hypothalamus releasing factor
½Ã»óÇϺÎÀ¯¸®ÀÎÀÚ.
inhibition(-tory) factor, macrophage migration
´ë½Ä¼¼Æ÷ À¯ÁÖÀúÁöÀÎÀÚ
intensity factor
°µµÀÎÀÚ
plasma coagulation factor
Ç÷ÀåÀÀ°íÀÎÀÚ
plasma factor
Ç÷ÀåÀÎÀÚ(úìíìì×í), ÇöóÁÀÎÀÚ.
plasma factor
Ç÷ÀåÀÎÀÚ(úìíìì×í), ÇöóÁÀÎÀÚ(¡ì×í)
plasma thromboplastic factor
Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ.
plasma thromboplastin factor
Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ.
platelet activating factor
Ç÷¼ÒÆÇ Ȱ¼º ÀÎÀÚ
platelet factor 4
Ç÷¼ÒÆÇÀÎÀÚ(úìá³÷ùì×í) 4
platelet factor 4=PF4
Ç÷¼ÒÆÇÀÎÀÚ 4
platelet factor III
Ç÷¼ÒÆÇÁ¦»ïÀÎÀÚ.
platelet-activating factor (PAF)
Ç÷¼ÒÆÇ Ȱ¼ºÈÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
dose modifying factor
¼±·®¼ö½Ä°è¼ö
dose-reduction factor
¼±·®°¨¼Ò°è¼ö
drug resistance factor
¾àÁ¦³»¼ºÀÎÀÚ
drug resistance transfer factor
¾àÁ¦³»¼ºÀü´ÞÀÎÀÚ
duplicate factor
Áߺ¹ÀÎÀÚ.
early pregnancy factor(EPF)
ÃʱâÀÓ½ÅÀÎÀÚ
edaphic factor
ÅäÁöÀÎÀÚ(ÊÙËöËö).
elongation factor
¿¬ÀåÀÎÀÚ(¡ì×í).
elongation factor
½ÅÀåÀÎÀÚ
enabling factor
ÀÇ·áÀÌ¿ë °¡´É¿äÀÎ.
encephalitogenic factor
³ú¿°À¯¹ßÀÎÀÚ
encephalitogenic factor
³ú¿°À¯¹ßÀÎÀÚ.
endothelial cell growth factor
³»ÇǼ¼Æ÷ Áõ½ÄÀÎÀÚ
endothelium-derived contracting factor (EDCF)
³»ÇǼ¼Æ÷¼º¼öÃàÀÎÀÚ(Ò®ù«á¬øààõâ¥õêì×í)
endothelium-derived relaxing factor
³»ÇǼ¼Æ÷¼º ÀÌ¿ÏÀÎÀÚ.
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½